Rockwell (RMTI), NxStage (NXST) Enter Manufacturing Agreement
Rockwell Medical Technologies (NASDAQ: RMTI) has signed a contract with NxStage Medical, Inc. (Nasdaq: NXST) to manufacture dialysate concentrate for the NxStage System One", the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration. The contract term is for two years.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Receives CRL from FDA on Parsabiv NDA
- Gilead Sciences' (GILD) Treatment of Pulmonary Arterial Hypertension Granted Orphan Drug Status by FDA
- Corium Internation (CORI) Reports Streamlined Bioequivalence Development Path for Transdermal Corplex
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!